Prevalence and Clinical Attributes of Congenital Microcephaly - New York, 2013-2015

Insights

Before Zika virus importation, severe congenital microcephaly affected 4.2 per 10,000 New York births. Surveillance data identified cases, noting higher prevalence in Black and Hispanic infants.

Area of Science:

  • Pediatric Neurology
  • Public Health Surveillance
  • Epidemiology

Background:

  • Congenital Zika virus infection is linked to microcephaly and severe fetal neurological anomalies.
  • Understanding microcephaly prevalence is crucial for surveillance and assessing data sources.
  • This study predates significant Zika virus importation into New York.

Purpose of the Study:

  • To determine the prevalence of microcephaly in New York from 2013-2015.
  • To evaluate ascertainment sources for microcephaly surveillance.
  • To characterize demographic and risk factors associated with severe congenital microcephaly.

Main Methods:

  • Identified suspected newborn microcephaly diagnoses from hospital reports and administrative discharge data.
  • Collected anthropometric measurements, maternal demographics, and pregnancy characteristics.
  • Classified diagnoses using CDC and National Birth Defects Prevention Network (NBDPN) case definitions.

Main Results:

  • A prevalence of 4.2 per 10,000 live births for severe congenital microcephaly was observed (284 cases).
  • Both hospital reports (93%) and administrative data (90%) effectively identified cases.
  • Black (30%) and Hispanic (31%) infants had disproportionately higher rates compared to live births.

Conclusions:

  • Severe congenital microcephaly occurred at a notable rate in New York prior to Zika virus importation.
  • Dual surveillance methods (hospital reports and administrative data) are effective for case ascertainment.
  • Disparities in prevalence among racial/ethnic groups and associations with maternal factors warrant further investigation.

Related Concept Videos